Salvia divinorum evidence profile

Salvia divinorum is a plant preparation, while salvinorin A is the principal measured psychoactive constituent.

Category: psychedelic · Updated: August 7, 2026

Sources and model notes are maintained by . This page is educational, not clinical guidance. Corrections: admin@halflifedb.co.

Model statusNo curve publishedCurrent sources do not support one defensible human input
Evidence boundarySource note onlyNo animal, forensic, mixture, or proxy value is presented as a human half-life
Model scopeNot modeledThe profile explains what the available records can and cannot establish
References3Linked studies, labels, reviews, or identity records described below

Salvia divinorum: evidence and interpretation notes

Why HalfLifeDB does not plot Salvia divinorum

Salvia divinorum is a plant preparation, while salvinorin A is the principal measured psychoactive constituent. The current sources emphasize preclinical and general drug-profile evidence rather than a representative human elimination half-life.

What each source contributes

  • PubChem: Salvia divinorum. This identity record confirms names and compound identity and does not supply a human half-life.
  • The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies. This synthesis organizes the available literature and caveats and cannot replace checking the underlying study design.
  • EUDA drug profile: Salvia divinorum. This synthesis organizes the available literature and caveats and cannot replace checking the underlying study design.

For Salvia divinorum, the decision to withhold a curve turns on the limits visible in The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies. This synthesis organizes the available literature and caveats, but it cannot replace checking the underlying study design.

What evidence would change the page

The next useful evidence for Salvia divinorum would be a direct human pharmacokinetic study with a defined exposure context and sufficient late sampling. Without that, converting The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies into a first-order midpoint would overstate what its design can support.

InterpretationCategory context and evidence limits

psychedelic context

Psychedelic duration is shaped by pharmacodynamics as well as pharmacokinetics, so subjective effects may not track a simple elimination curve.

  • The curve does not predict psychological effects or functional safety.
  • Metabolites and downstream receptor activity are not separately modeled.
  • Published estimates may come from small or specialized study populations.
EvidenceSource trail and model decision

Sources and evidence context

A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.

1 PubMed0 PMC0 DailyMed1 PubChem
  1. Identity record PubChem Compound Summary: Salvia divinorum.
    Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
  2. Research abstract PubMed: The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies.
    Preclinical review; useful for context but weaker than direct human pharmacokinetic data.
  3. Peer-reviewed source EUDA drug profile: Salvia divinorum.
    Synthesis or clinical background source used to frame the evidence and its limits rather than to create a new measured value.
BoundariesWhat this page cannot answer and where to continue

What this page does not answer

  • It does not estimate impairment, intoxication, or fitness to drive.
  • It does not predict urine, blood, saliva, or hair test results.
  • It does not model repeated exposure, tolerance, withdrawal, or interactions.
  • It does not replace clinician, pharmacist, toxicologist, or emergency guidance.

Continue with context

Read the medical disclaimer, methodology, and research standards before using the model for comparison.